Suppr超能文献

人载脂蛋白A-IV:被HDL2相关C-载脂蛋白从富含甘油三酯颗粒表面置换下来。

Human apolipoprotein A-IV: displacement from the surface of triglyceride-rich particles by HDL2-associated C-apoproteins.

作者信息

Weinberg R B, Spector M S

出版信息

J Lipid Res. 1985 Jan;26(1):26-37.

PMID:3973511
Abstract

Human apolipoprotein A-IV rapidly dissociates from the surface of lymph chylomicrons following their entry into circulation by an unknown mechanism. We have therefore investigated the binding of human apoA-IV to triglyceride-rich particles and the interaction of these apoA-IV/lipid complexes with human HDL2. Human apoA-IV was purified from lipoprotein depleted serum (J. Lipid Res. 1983. 24:52-59). Triglyceride-rich particles of well-defined properties were isolated from Intralipid, a commercially available phospholipid-triglyceride emulsion. Various concentrations of radiolabeled human apoA-IV were incubated at 24 degrees C with a fixed quantity of lipid particles; the particles were reisolated by centrifugation, and bound and free apoA-IV were quantitated. In 50 mM Tris, pH 7.4, apoA-IV bound to the triglyceride-rich particles in a non-cooperative manner, with a Kd of 2.0 microM. The calculated maximal binding was 4.96 X 10(-4) mol of apoA-IV bound per mol of phospholipid. The addition of increasing amounts of human HDL2 to the incubations caused the progressive dissociation of apoA-IV from the triglyceride-rich particles. Analysis of the reisolated particles by isoelectric focusing demonstrated the presence of C-apoproteins, suggesting their transfer from HDL2. Addition of purified apoC-III-1 to the incubations at concentrations equivalent to those present in HDL2 caused a similar dissociation of apoA-IV. HDL2 was modified to selectively remove C-apoproteins, without alteration of other physical characteristics. This modified HDL2 was four times less effective in causing apoA-IV dissociation. These results demonstrate that the lipid binding properties of human apoA-IV may be quantitatively examined using triglyceride-rich particles as model chylomicrons. This approach reproduces in vitro the dissociation of apoA-IV that occurs in vivo when mesenteric lymph chylomicrons enter the circulation, and suggests that the primary mechanism for this phenomenon is the transfer of C-apoproteins from high density lipoproteins to the triglyceride-rich particle surface. We hypothesize that this mechanism may play an important role in the modulation of chylomicron apoA-IV content in man.

摘要

人类载脂蛋白A-IV在通过未知机制进入循环后,会迅速从淋巴乳糜微粒表面解离。因此,我们研究了人类载脂蛋白A-IV与富含甘油三酯的颗粒的结合情况,以及这些载脂蛋白A-IV/脂质复合物与人类高密度脂蛋白2(HDL2)的相互作用。人类载脂蛋白A-IV从脂蛋白缺乏的血清中纯化得到(《脂质研究杂志》,1983年,24卷:52 - 59页)。从市售的磷脂 - 甘油三酯乳剂英脱利匹特(Intralipid)中分离出性质明确的富含甘油三酯的颗粒。将各种浓度的放射性标记的人类载脂蛋白A-IV在24℃下与固定量的脂质颗粒一起孵育;通过离心重新分离颗粒,并对结合型和游离型载脂蛋白A-IV进行定量。在50 mM Tris,pH 7.4的条件下,载脂蛋白A-IV以非协同方式与富含甘油三酯的颗粒结合,解离常数(Kd)为2.0 microM。计算得出的最大结合量为每摩尔磷脂结合4.96×10⁻⁴摩尔的载脂蛋白A-IV。向孵育体系中添加越来越多的人类HDL2会导致载脂蛋白A-IV从富含甘油三酯的颗粒上逐渐解离。通过等电聚焦对重新分离的颗粒进行分析,表明存在C-载脂蛋白,提示它们是从HDL2转移而来。以与HDL2中相同的浓度向孵育体系中添加纯化的载脂蛋白C-III-1会导致类似的载脂蛋白A-IV解离。对HDL2进行修饰以选择性去除C-载脂蛋白,同时不改变其他物理特性。这种修饰后的HDL2在导致载脂蛋白A-IV解离方面的效果降低了四倍。这些结果表明,使用富含甘油三酯的颗粒作为模型乳糜微粒,可以对人类载脂蛋白A-IV的脂质结合特性进行定量研究。这种方法在体外重现了肠系膜淋巴乳糜微粒进入循环时在体内发生的载脂蛋白A-IV解离现象,并提示这种现象的主要机制是C-载脂蛋白从高密度脂蛋白转移到富含甘油三酯的颗粒表面。我们推测这种机制可能在调节人体乳糜微粒载脂蛋白A-IV含量中起重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验